MedStar Authors catalog › Details for: TCT-39 Three-Year Outcomes with the Fully Repositionable and Retrievable LotusTM Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study.
Normal view MARC view ISBD view

TCT-39 Three-Year Outcomes with the Fully Repositionable and Retrievable LotusTM Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study.

by Redwood, Simon.
Citation: Journal of the American College of Cardiology. 68(18S):B16-B17, 2016 Nov 01.Journal: Journal of the American College of Cardiology.Published: 2016ISSN: 0735-1097.Full author list: Meredith I; Houle V; Walters D; Dumonteil N; Worthley S; Tchetche D; Manoharan G; Blackman D; Rioufol G; Hildick-Smith D; Whitbourn R; Lefevre T; Lange R; Mueller R; Redwood S; Allocco DJ.UI/PMID: 27969744.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.jacc.2016.09.176 (Click here) Abbreviated citation: J Am Coll Cardiol. 68(18S):B16-B17, 2016 Nov 01.Local Holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007.

Powered by Koha